Case Studies

Challenge
A leading pharmaceutical company faced a critical supply chain challenge requiring the procurement of thousands of product packs, each originating from distinct lots, to support their bioequivalence studies. Meeting the stringent lot-specific requirements within a compressed timeframe presented a significant logistical hurdle.

Solution
The Rx MediSource team successfully addressed this complex challenge by efficiently sourcing the required products that precisely matched the client’s lot specifications. Through meticulous planning and execution, we were able to secure products with the optimal expiration dates available in the market, ensuring the timely commencement and successful completion of the client’s biostudies.

Challenge
A prominent oncology pharmaceutical manufacturer encountered a critical supply chain disruption with an acute shortage of a US-approved branded oncology drug. This scarcity posed a significant threat to ongoing clinical trials and patient care.

Solution
In response to this urgent challenge, the Rx MediSource team collaborated with a global partner to rapidly identify and procure the required oncology drug. Through diligent market analysis and strategic sourcing, we successfully secured the product with an extended expiration date while achieving a cost reduction compared to prevailing market prices. This expedited solution mitigated supply chain risks and ensured the continuity of the client’s critical operations.

Challenge
A leading pharmaceutical organization sought to procure China-approved drugs for critical study and regulatory filing purposes. The Chinese market presented significant challenges due to stringent supply controls and limited product availability, hindering the organization’s research and development efforts.

Solution
Through strategic partnerships and a deep understanding of the Chinese pharmaceutical landscape, the Rx MediSource team successfully sourced the required drugs from three distinct batches, each comprising 58 packs. Despite the market’s complexities and time constraints, we were able to expedite the procurement process and deliver genuine products, ensuring the client’s research and development initiatives remained on track.

Challenge
A client required a substantial quantity of an EU-approved drug for a critical study, with the specific stipulation that all product units must originate from a single manufacturing lot. This was further complicated by stringent supply regulations imposed on the drug.

Solution
Through strategic collaboration with our trusted European partners, Rx MediSource successfully overcame the challenges of supply restrictions and lot traceability. Within a compressed timeframe, our team secured 92 units of the required drug from a single lot, despite the market’s stringent allocation of only five units per month. This achievement was made possible through our in-depth understanding of the European pharmaceutical market and our established network of suppliers.

Challenge
A key client faced a critical supply chain disruption that threatened to derail an ongoing clinical trial. With less than a week to secure and deliver US-approved injectables to the study site, the client was under immense pressure to avoid substantial financial penalties associated with trial delays. The situation was exacerbated by acute product shortages and limited market availability.

Solution
In response to this urgent crisis, the Rx MediSource team implemented a round-the-clock response, coordinating efforts across multiple time zones to expedite product acquisition. Through diligent market analysis and leveraging our extensive supplier network, we successfully secured the required injectables and delivered them to the clinical trial site one day ahead of the critical deadline. The swift and decisive action prevented a costly clinical trial delay and ensured the continuity of the client’s research.

Challenge
A leading global pharmaceutical manufacturer sought a strategic solution to mitigate losses associated with a substantial volume of surplus, near-expiration pharmaceutical products. The client required a rapid and efficient strategy to recover maximum value from this obsolete inventory.

Solution
Through collaborative efforts with industry partners, our team developed and implemented a comprehensive disposition plan for the majority of the client’s surplus pharmaceuticals. Rigorous inventory management, including meticulous data tracking and adherence to stringent storage conditions, ensured product integrity throughout the process. As a result, the client realized a 40% recovery of their initial investment in the obsolete inventory.

Challenge
Many organizations conducting clinical studies encounter significant difficulties in acquiring necessary medical devices from diverse global markets, including the United States, Europe, China, and the rest of the world. These devices range from simple consumables such as tubes and syringes to more complex equipment like nebulizers. The procurement of these items often presents complex logistical and budgetary obstacles.

Solution
Rx MediSource specializes in overcoming these procurement hurdles. Through our expertise and established global network, we consistently deliver the required medical devices at competitive prices, ensuring timely availability to support our clients’ research endeavors.

Challenge
Multiple clients expressed an urgent need for a specific oncology medication recently approved by the U.S. Food and Drug Administration (FDA). Due to the drug’s novel status, market supply was extremely limited.

Solution
Leveraging the Rx MediSource established network, we implemented a rapid response strategy to procure the required oncology drug directly from the manufacturer. Stringent confidentiality protocols were maintained throughout the process. This expedited solution ensured the timely delivery of the medication to meet our clients’ critical needs.

Challenge
A prominent pharmaceutical client entrusted our organization with storing a US FDA-approved drug for future distribution. Due to unforeseen project delays, the product reached its expiration date while in our custody.

Solution
In collaboration with our industry partners, Rx MediSource implemented a recovery strategy to salvage the expired drug directly from the manufacturer. This proactive approach enabled the client to recoup a substantial portion of their initial investment.